Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 19 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ADRA1A
💬1. ADRA1A
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 7件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Methylergometrine
Methylergometrine
💬1. ADRA1A
| Methylergometrine | 1件: 280 280 💬1. ADRA1A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
ADRA1B
💬2. ADRA1B
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Methylergometrine
Methylergometrine
💬2. ADRA1B
| Methylergometrine | 1件: 280 280 💬2. ADRA1B
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
ADRA1D
💬3. ADRA1D
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion 6件: Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, ... | Methylergometrine
Methylergometrine
💬3. ADRA1D
| Methylergometrine | 1件: 280 280 💬3. ADRA1D
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
ADRA2A
💬4. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬4. ADRA2A
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬4. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
ADRA2A
💬5. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Methylergometrine
Methylergometrine
💬5. ADRA2A
| Methylergometrine | 1件: 280 280 💬5. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
ADRA2B
💬6. ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬6. ADRA2B
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬6. ADRA2B
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
ADRA2B
💬7. ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Methylergometrine
Methylergometrine
💬7. ADRA2B
| Methylergometrine | 1件: 280 280 💬7. ADRA2B
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
ADRA2C
💬8. ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Methylergometrine
Methylergometrine
💬8. ADRA2C
| Methylergometrine | 1件: 280 280 💬8. ADRA2C
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
ADRA2C
💬9. ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬9. ADRA2C
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬9. ADRA2C
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
HMGCR
💬10. HMGCR
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion | Lovastatin
Lovastatin
💬10. HMGCR
| Lovastatin | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬10. HMGCR
|